Fidelity Advisor Biotechnology Fund - Class C (FBTCX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
28.86
-0.07 (-0.24%)
At close: Feb 13, 2026

FBTCX Holdings Information

FBTCX is a mutual fund with a total of 88 individual holdings. The top holdings are AbbVie stock at 17.22%, Alnylam Pharmaceuticals at 6.31%, Gilead Sciences at 5.75%, argenx SE at 4.55%, and Ascendis Pharma at 4.29%.

Total Holdings
88
Top 10 Percentage
53.99%
Asset Class
Equity
Fund Category
Health
Assets
1.87B
Forward PE Ratio
18.05

Breakdown by Sector

Top 25 Holdings

No.SymbolName WeightShares
1ABBVAbbVie Inc.17.22%1,389,580
2ALNYAlnylam Pharmaceuticals, Inc.6.31%292,486
3GILDGilead Sciences, Inc.5.75%864,100
4ARGXargenx SE4.55%99,700
5ASNDAscendis Pharma A/S4.29%370,625
6COGTCogent Biosciences, Inc.3.98%2,063,018
7INSMInsmed Incorporated3.40%360,500
8VRDNViridian Therapeutics, Inc.3.01%1,782,464
9BIIBBiogen Inc.2.81%294,100
10AMGNAmgen Inc.2.68%150,703
11NUVLNuvalent, Inc.2.25%412,264
12PCVXVaxcyte, Inc.2.21%883,929
13APGEApogee Therapeutics, Inc.1.85%452,639
14GPCRStructure Therapeutics Inc.1.82%481,200
15XENEXenon Pharmaceuticals Inc.1.73%710,758
16DNTHDianthus Therapeutics, Inc.1.63%730,062
17AMLXAmylyx Pharmaceuticals, Inc.1.59%2,433,200
18CYTKCytokinetics, Incorporated1.51%436,771
19SRRKScholar Rock Holding Corporation1.39%582,368
20EBR: UCBUCB SA1.39%91,100
21CRNXCrinetics Pharmaceuticals, Inc.1.37%544,470
22MRNAModerna, Inc.1.37%856,900
23VKTXViking Therapeutics, Inc.1.35%706,987
24SYRESpyre Therapeutics, Inc.1.33%749,342
25QUREuniQure N.V.1.29%991,600
Showing 25 of 88 holdings
Subscribe to see the full list
As of Dec 31, 2025